# Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia

> **NCT01081964** · PHASE2 · TERMINATED · sponsor: **IASO Pharma Inc.** · enrollment: 48 (actual)

## Conditions studied

- Community Acquired Pneumonia

## Interventions

- **DRUG:** Zabofloxacin
- **DRUG:** Levofloxacin 500mg
- **DRUG:** Zabofloxacin 400mg

## Key facts

- **NCT ID:** NCT01081964
- **Lead sponsor:** IASO Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-06
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** Financial considerations
- **Last updated:** 2012-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01081964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01081964, "Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01081964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*